Literature DB >> 10640923

Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency.

P A Klein1, J P Callen.   

Abstract

Linear IgA bullous dermatosis (LABD) is an autoimmune, subepidermal, vesiculobullous disease that has been commonly associated with the use of vancomycin hydrochloride. Lesions typically appear during vancomycin therapy, 24 hours to 15 days after the first dose. A 65-year-old white man with renal insufficiency developed pruritic, tense bullae on the right chest, right medial arm, right flank, abdomen, and right upper thigh 14 days after his last dose of vancomycin. Histopathologic examination and immunofluorescence studies were diagnostic of LABD. Vancomycin-related LABD may appear as long as 2 weeks after the drug is discontinued.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640923     DOI: 10.1016/s0190-9622(00)90102-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Authors:  Bethsabée Garel; Saskia Ingen-Housz-Oro; Daniele Afriat; Catherine Prost-Squarcioni; Florence Tétart; Benoit Bensaid; Corina Bara Passot; Marie Beylot-Barry; Vincent Descamps; Sophie Duvert-Lehembre; Sabine Grootenboer-Mignot; Géraldine Jeudy; Angèle Soria; Marie Blanche Valnet-Rabier; Annick Barbaud; Frédéric Caux; Bénédicte Lebrun-Vignes
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

Review 2.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

3.  Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment.

Authors:  Maciej Pastuszczak; Sylwia Lipko-Godlewska; Andrzej K Jaworek; Anna Wojas-Pelc
Journal:  J Dermatol Case Rep       Date:  2012-12-31

Review 4.  Vancomycin revisited - 60 years later.

Authors:  Ethan Rubinstein; Yoav Keynan
Journal:  Front Public Health       Date:  2014-10-31

5.  Bullous Dermatosis in an End-Stage Renal Disease Patient: A Case Report and Literature Review.

Authors:  Zeenat Yousuf Bhat; Marwan Abu Minshar; Nashat Imran; Andrew Thompson; Yahya Osman Malik
Journal:  Case Rep Nephrol       Date:  2016-11-24

Review 6.  Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis.

Authors:  Amanda Regio Pereira; Luis Henrique Barbizan de Moura; Jhonatan Rafael Siqueira Pinheiro; Victor Pavan Pasin; Milvia Maria Simões E Silva Enokihara; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

7.  A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis.

Authors:  Pinky Jha; Kurtis Swanson; Jeremiah Stromich; Basia M Michalski; Edit Olasz
Journal:  Case Rep Dermatol Med       Date:  2017-01-10

8.  Linear IgA bullous dermatosis: a rare side effect of vancomycin.

Authors:  Pradeep K Selvaraj; Faisal A Khasawneh
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.